本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Faeth Therapeutics

35.63
-3.4600-8.85%
成交量:13.36萬
成交額:500.34萬
市值:9.18億
市盈率:-0.25
高:39.89
開:38.75
低:35.60
收:39.09
52周最高:42.14
52周最低:7.45
股本:2,577.88萬
流通股本:81.17萬
量比:0.53
換手率:16.46%
股息:- -
股息率:- -
每股收益(TTM):-141.6499
每股收益(LYR):-16.7239
淨資產收益率:-195.26%
總資產收益率:-20.79%
市淨率:5.31
市盈率(LYR):-2.13

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

重要事件披露

Form 8-K - Current report
2026/08/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/24

重要事件披露

Form 8-K - Current report
2026/06/23

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/23

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/19

重要事件披露

Form 8-K - Current report
2026/06/15

重要事件披露

Form 8-K - Current report
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/03

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/02

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/21

重要事件披露

Form 8-K - Current report
2026/05/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors